Treatment of Patellar Chondral Lesions With Concomitant Matrix-Induced Autologous Chondrocyte Implantation, Medial Patellofemoral Ligament Reconstruction, and Tibial Tubercle Osteotomy
The US Food and Drug Administration approved matrix-induced autologous chondrocyte implantation (MACI) for use in the United States in 2016, and it has proven to be an effective treatment for articular cartilage defects in the knee. Concomitant patellar stabilization and realignment procedures, such...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-09-01
|
| Series: | Arthroscopy Techniques |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2212628724001683 |